4.6 Review

Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential

期刊

FRONTIERS IN ONCOLOGY
卷 12, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2022.773840

关键词

radiomics; deep learning; multi-modality images; precision diagnosis and treatment; dosiomics

类别

资金

  1. National Natural Science Foundation of China [61971118]
  2. Science and Technology Program of Guangzhou [202102010472]

向作者/读者索取更多资源

Radiomics, as a rapidly developing research field, focuses on the high-throughput extraction of quantitative imaging features from medical images for analysis and assessment of different tissues and organs. This article reviews the recent developments in radiomic analysis, including feature extraction, segmentation, statistical analysis, and model construction, as well as explores deep learning-based techniques for automatic segmentation and radiomic analysis. The applications of radiomics in disease diagnosis, treatment response, and prognosis prediction are discussed, highlighting its potential and value in clinical practice. Moreover, challenges and recommendations for future development are presented, considering factors that affect model stability, limitations of data-driven processes, and thoughts on achieving clinical applications and an open platform for radiomics analysis.
The high-throughput extraction of quantitative imaging features from medical images for the purpose of radiomic analysis, i.e., radiomics in a broad sense, is a rapidly developing and emerging research field that has been attracting increasing interest, particularly in multimodality and multi-omics studies. In this context, the quantitative analysis of multidimensional data plays an essential role in assessing the spatio-temporal characteristics of different tissues and organs and their microenvironment. Herein, recent developments in this method, including manually defined features, data acquisition and preprocessing, lesion segmentation, feature extraction, feature selection and dimension reduction, statistical analysis, and model construction, are reviewed. In addition, deep learning-based techniques for automatic segmentation and radiomic analysis are being analyzed to address limitations such as rigorous workflow, manual/semi-automatic lesion annotation, and inadequate feature criteria, and multicenter validation. Furthermore, a summary of the current state-of-the-art applications of this technology in disease diagnosis, treatment response, and prognosis prediction from the perspective of radiology images, multimodality images, histopathology images, and three-dimensional dose distribution data, particularly in oncology, is presented. The potential and value of radiomics in diagnostic and therapeutic strategies are also further analyzed, and for the first time, the advances and challenges associated with dosiomics in radiotherapy are summarized, highlighting the latest progress in radiomics. Finally, a robust framework for radiomic analysis is presented and challenges and recommendations for future development are discussed, including but not limited to the factors that affect model stability (medical big data and multitype data and expert knowledge in medical), limitations of data-driven processes (reproducibility and interpretability of studies, different treatment alternatives for various institutions, and prospective researches and clinical trials), and thoughts on future directions (the capability to achieve clinical applications and open platform for radiomics analysis).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

Prospective clinical research of radiomics and deep learning in oncology: A translational review

Xingping Zhang, Yanchun Zhang, Guijuan Zhang, Xingting Qiu, Wenjun Tan, Xiaoxia Yin, Liefa Liao

Summary: This review summarizes the characteristics and advancements of radiomics and deep learning in oncology, and discusses their clinical utility and methodological robustness. It also identifies the barriers and proposes solutions for integrating these methods into clinical practice.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

暂无数据